FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

F-box and WD repeat domain-containing 7 (FBW7) has been characterized as a tumor suppressor, and its mutation or decreased expression has been observed in many types of human cancers. Our recent studies have uncovered that in pancreatic cancer, the KRAS mutation decreased FBW7 expression through pho...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncol Rep
Hoofdauteurs: Hu, Qiangsheng, Qin, Yi, Zhang, Bo, Liang, Chen, Ji, Shunrong, Shi, Si, Xu, Wenyan, Xiang, Jinfeng, Liang, Dingkong, Ni, Quanxing, Yu, Xianjun, Xu, Jin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2017
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652962/
https://ncbi.nlm.nih.gov/pubmed/28765935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5856
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items